The Deputy Head of the Food and Drug Organization outlined the performance of the country's pharmaceutical market in the first half of the year 1405, stating that the total rial sales of drugs during this period reached approximately 400 trillion rials, which shows a 155% increase compared to the 157 trillion rials sold in the same period last year.
Sales of 400 Trillion Rials in Pharmaceuticals in the First Half of This Year / Names of Best-Selling Drugs Announced
The Iranian pharmaceutical market saw a significant increase in sales, reaching 400 trillion rials in the first half of the year 1405, marking a 155% growth compared to the previous year. This highlights the growing demand and possibly inflationary pressures in the healthcare sector.
👥 Key Players
📰 What Happened
The Iranian pharmaceutical market reported sales of 400 trillion rials in the first half of the year 1405, a 155% increase from the previous year. This surge indicates rising demand and potential inflationary trends in the healthcare sector.
- Total drug sales reached approximately 400 trillion rials.
- This marks a 155% increase compared to 157 trillion rials sold in the same period last year.
💡 Why It Matters
📚 Background
Iran's pharmaceutical industry has been under strain due to economic sanctions and inflation, impacting drug availability and prices. Understanding this context is essential for grasping the significance of the sales figures.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%